BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15506920)

  • 1. Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases.
    Marmorstein R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):904-9. PubMed ID: 15506920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and autoregulation of the yeast Hst2 homolog of Sir2.
    Zhao K; Chai X; Clements A; Marmorstein R
    Nat Struct Biol; 2003 Oct; 10(10):864-71. PubMed ID: 14502267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
    Zhao K; Harshaw R; Chai X; Marmorstein R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the histone deacetylase SIRT2.
    Finnin MS; Donigian JR; Pavletich NP
    Nat Struct Biol; 2001 Jul; 8(7):621-5. PubMed ID: 11427894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
    Imai S; Armstrong CM; Kaeberlein M; Guarente L
    Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assays for characterization of the Sir2 family of NAD(+)-dependent deacetylases.
    Borra MT; Denu JM
    Methods Enzymol; 2004; 376():171-87. PubMed ID: 14975305
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
    Khan AN; Lewis PN
    J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in the Sir2 family of protein deacetylases.
    Buck SW; Gallo CM; Smith JS
    J Leukoc Biol; 2004 Jun; 75(6):939-50. PubMed ID: 14742637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the yeast Hst2 protein deacetylase in ternary complex with 2'-O-acetyl ADP ribose and histone peptide.
    Zhao K; Chai X; Marmorstein R
    Structure; 2003 Nov; 11(11):1403-11. PubMed ID: 14604530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of Alba, a conserved archaeal chromatin protein, with Sir2 and its regulation by acetylation.
    Bell SD; Botting CH; Wardleworth BN; Jackson SP; White MF
    Science; 2002 Apr; 296(5565):148-51. PubMed ID: 11935028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in Saccharomyces cerevisiae gene SIR2 can have differential effects on in vivo silencing phenotypes and in vitro histone deacetylation activity.
    Armstrong CM; Kaeberlein M; Imai SI; Guarente L
    Mol Biol Cell; 2002 Apr; 13(4):1427-38. PubMed ID: 11950950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
    Sauve AA; Schramm VL
    Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
    Sauve AA; Schramm VL
    Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin-independent effects of nicotinamide on lifespan extension from calorie restriction in yeast.
    Tsuchiya M; Dang N; Kerr EO; Hu D; Steffen KK; Oakes JA; Kennedy BK; Kaeberlein M
    Aging Cell; 2006 Dec; 5(6):505-14. PubMed ID: 17129213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sir2 family of protein deacetylases.
    Blander G; Guarente L
    Annu Rev Biochem; 2004; 73():417-35. PubMed ID: 15189148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for step-wise assembly of heterochromatin in yeast.
    Moazed D; Rudner AD; Huang J; Hoppe GJ; Tanny JC
    Novartis Found Symp; 2004; 259():48-56; discussion 56-62, 163-9. PubMed ID: 15171246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and substrate binding properties of cobB, a Sir2 homolog protein deacetylase from Escherichia coli.
    Zhao K; Chai X; Marmorstein R
    J Mol Biol; 2004 Mar; 337(3):731-41. PubMed ID: 15019790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the NAD-dependent deacetylase mechanism of Sir2.
    Chang JH; Kim HC; Hwang KY; Lee JW; Jackson SP; Bell SD; Cho Y
    J Biol Chem; 2002 Sep; 277(37):34489-98. PubMed ID: 12091395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.